Phase 1 Study of Pomalidomide Given at the Time of Early Lymphocyte Recovery after Induction Timed Sequential Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS)
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Joshua F. Zeidner, Raul Montiel-Esparza, Hanna A. Knaus, Sofia Berglund, Amer M. Zeidan, Shannon R. McCurdy, Gabrielle T Prince, Lukasz P Gondek, Gabriel Ghiaur, Margaret M. Showel, Amy E. DeZern, Keith W. Pratz, B. Douglas Smith, Mark J. Levis, Matthew C Foster, Katarzyna Jamieson, Hendrik W. Van Deventer, Howard Streicher, Judith E. Karp, Leo Luznik, Ivana Gojo
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2770088154